Bahathiq Ali, Abbas Marwah, Al Fareh Nojoud A
Psychiatry, King Saud University, Riyadh, SAU.
Psychiatry, King Khalid University Hospital, Riyadh, SAU.
Cureus. 2025 Jun 12;17(6):e85849. doi: 10.7759/cureus.85849. eCollection 2025 Jun.
Hiccups, or Singultus, are a common condition among individuals. Several medications are under research for hiccup management, including Gabapentin, an analog of the neurotransmitter γ-aminobutyric acid (GABA), which has shown effective outcomes in patients with persistent hiccups, highlighting the need for larger clinical studies to evaluate their efficacy and safety. Despite that, Gabapentin works on the α-2-δ subunit of calcium channels, mediating its effect. Like many hiccup treatments, the exact mechanism through which Gabapentin alleviates hiccups is not fully understood. This case reports an 87-year-old male with a 40-year history of chronic hiccups, unresponsive to traditional psychiatric treatments, including chlorpromazine and haloperidol. The patient began escitalopram 20 mg daily for low mood and later added gabapentin 300 mg three times a day, which significantly improved his hiccups to under 15 minutes daily without any side effects. This case highlights the efficacy and safety of Gabapentin as an effective and well-tolerated treatment for persistent hiccups of unknown cause.
打嗝,即呃逆,是一种常见的症状。目前正在研究多种用于治疗打嗝的药物,包括加巴喷丁,它是神经递质γ-氨基丁酸(GABA)的类似物,已在持续性打嗝患者中显示出有效结果,这凸显了开展更大规模临床研究以评估其疗效和安全性的必要性。尽管如此,加巴喷丁作用于钙通道的α-2-δ亚基来介导其效应。与许多打嗝治疗方法一样,加巴喷丁缓解打嗝的确切机制尚未完全明确。本病例报告了一名87岁男性,有40年慢性打嗝病史,对包括氯丙嗪和氟哌啶醇在内的传统精神科治疗均无反应。该患者因情绪低落开始每日服用20毫克艾司西酞普兰,后来添加了每日三次每次300毫克的加巴喷丁,这使其打嗝次数显著减少至每天不到15分钟,且无任何副作用。本病例突出了加巴喷丁作为一种治疗不明原因持续性打嗝的有效且耐受性良好的药物的疗效和安全性。